FUNCTIONAL AREAS – Page 15

Analyst technique variability during method transfer – improving right-first-time testing metrics

The first step in addressing analyst technique variability is identifying symptoms or signals indicating the existence of the problem. Some common signs in the laboratory or production environment include:Click to…

Unapproved integration changes during sample management – improving right-first-time testing metrics

Identifying symptoms of unapproved integration changes is the first step toward a successful investigation. Symptoms may manifest both in physical environments on the manufacturing floor and within the laboratory setting.…

Unapproved integration changes in routine release testing – CAPA package with objective evidence

Recognizing the symptoms of unapproved integration changes is the initial step in addressing the issue. Symptoms may manifest in various ways, including:Click to read the full article.

System suitability failure ignored during investigation phase – FDA data integrity risk and corrective actions

The first step in addressing a system suitability failure is identifying the symptoms or signals that indicate an issue is present. Common indicators include:Click to read the full article.

OOS investigation lacks root cause during sample management – CAPA package with objective evidence

Identifying symptoms of an OOS finding is the first step in addressing the issue effectively. Symptoms can surface in various forms and should be documented meticulously. Common signals include:Click to…

System suitability failure ignored during method transfer – improving right-first-time testing metrics

The initial detection of system suitability failures can manifest in various forms on the laboratory floor. Common symptoms include:Click to read the full article.

System suitability failure ignored in routine release testing – improving right-first-time testing metrics

Identifying symptoms or signals of a system suitability failure is the first critical step in managing the problem effectively. Specific indicators include:Click to read the full article.

Method transfer mismatch during method transfer – FDA data integrity risk and corrective actions

Identifying the symptoms or signals associated with a method transfer mismatch is the first step in addressing the issue. Common indicators may include:Click to read the full article.

OOS investigation lacks root cause in routine release testing – FDA data integrity risk and corrective actions

When an OOS result occurs, the first step is to gather symptoms and signals from both the manufacturing floor and laboratory that suggest an anomaly. Some common signals include:Click to…

System suitability failure ignored in routine release testing – documentation pack for regulator confidence

System suitability failures typically manifest as anomalies during testing that deviate from established acceptance criteria. Symptoms to watch for include:Click to read the full article.

Analyst technique variability in routine release testing – audit trail review steps inspectors expect

The initial identification of analyst technique variability can manifest through various signals within the lab or manufacturing process. Typical symptoms include:Click to read the full article.

System suitability failure ignored during sample management – FDA data integrity risk and corrective actions

Identifying early signals of system suitability failures is crucial in preventing compounded issues during analytical procedures. Some common symptoms may include:Click to read the full article.